Salient Capital Advisors’s UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN MLPL Stock Holding History

Salient Capital Advisors’s Portfolio MLPL Stock Details MLPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-95,161	Closed	-$2.11M	–	279
2015 Q4	$2.11M	Buy	95,161 +17,664	+23%	+$424K	0.06%	91
2015 Q3	$1.9M	Buy	77,497 +40,605	+110%	+$1.42M	0.05%	103
2015 Q2	$1.57M	Buy	36,892 +21,365	+138%	+$1.08M	0.03%	125
2015 Q1	$782K	Sell	15,527 -1,470	-9%	-$76.5K	0.01%	145
2014 Q4	$978K	Buy	16,997 +12,997	+325%	+$818K	0.02%	156
2014 Q3	$293K	Sell	4,000 -55	-1%	-$3.84K	0.01%	205
2014 Q2	$285K	Sell	4,055 -1,544	-28%	-$95.8K	0.01%	204
2014 Q1	$316K	Buy	5,599 +194	+4%	+$10.6K	0.01%	188
2013 Q4	$305K	Buy	+5,405	New	+$289K	0.01%	179
2013 Q3	–	Sell	-3,900	Closed	-$215K	–	179
2013 Q2	$215K	Buy	+3,900	New	+$204K	0.01%	149

Salient Capital Advisors's MLPL Position: Q1 2016 in Review

Salient Capital Advisors sold out of UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN (MLPL) in Q1 2016, closing a stake of 95,161 shares — an estimated $2.11M sold.

Salient Capital Advisors first reported a position in MLPL in Q2 2013 and held it in 10 quarters. The position peaked at $2.11M in Q4 2015. 0 funds tracked by Wall St. Rank hold MLPL as of Q1 2016.

Salient Capital Advisors reported no remaining UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN position as of Q1 2016 after selling out during the quarter.
Salient Capital Advisors sold 95,161 UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN shares in Q1 2016, an estimated $2.11M.
Salient Capital Advisors first reported a position in UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN in Q2 2013 and held it in 10 quarters.
Salient Capital Advisors's UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN position peaked at $2.11M in Q4 2015.
0 funds tracked by Wall St. Rank held UBS AG 2XMTHLY LEV LG EXCH TRD ACCESS SEC E-TRACS ALERIAN as of Q1 2016.

Based on Salient Capital Advisors's 13F filing for Q1 2016, filed 12 May 2016.